Cytokeratin 5 Antikörper
(2 Referenzen)-
- Target Alle Cytokeratin 5 (KRT5) Antikörper anzeigen
- Cytokeratin 5 (KRT5) (Keratin 5 (KRT5))
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser Cytokeratin 5 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunohistochemistry (IHC), ELISA, Flow Cytometry (FACS), Immunocytochemistry (ICC)
- Verwendungszweck
- CK5 Antibody
- Aufreinigung
- Purified antibody
- Immunogen
- Purified recombinant fragment of human CK5 expressed in E. Coli.
- Klon
- 2C2
- Isotyp
- IgG1
-
anti-Keratin 5 (KRT5) (AA 316-590) antibody
KRT5 Reaktivität: Human WB, IHC, ELISA, FACS Wirt: Maus Monoclonal 10C11E6 unconjugated
anti-Keratin 5 (KRT5) (AA 335-473) antibodyKRT5 Reaktivität: Ratte WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Keratin 5 (KRT5) (AA 316-590) antibodyKRT5 Reaktivität: Human IHC, StM Wirt: Maus Monoclonal KRT5-3594 unconjugated
anti-Keratin 5 (KRT5) (AA 258-357) antibodyKRT5 Reaktivität: Human WB, IHC, ELISA, FACS, ICC Wirt: Maus Monoclonal 3D6D4 unconjugated
anti-Keratin 5 (KRT5) (AA 258-357) antibodyKRT5 Reaktivität: Human WB, IHC, ELISA, FACS, ICC Wirt: Maus Monoclonal 2C8E4 unconjugated
anti-Keratin 5 (KRT5) antibodyKRT5 Reaktivität: Human WB, IHC, IF, IP Wirt: Kaninchen Polyclonal unconjugated
anti-Keratin 5 (KRT5) (AA 1-273) antibodyKRT5 Reaktivität: Human WB, IHC, IHC (p) Wirt: Maus Monoclonal 4A7 unconjugated
anti-Keratin 5 (KRT5) (AA 163-471) antibodyKRT5 Reaktivität: Maus WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Keratin 5 (KRT5) (AA 331-430) antibodyKRT5 Reaktivität: Human, Maus, Ratte WB, ELISA, FACS, IHC (p), IF (cc), IF (p), IHC (fro) Wirt: Kaninchen Polyclonal unconjugated
anti-Keratin 5 (KRT5) (AA 1-590) antibodyKRT5 Reaktivität: Human WB, ELISA, IP Wirt: Maus Monoclonal 1A12 unconjugated
-
- Applikationshinweise
-
ELISA: 1/10000
FCM: 1/200 - 1/400
ICC: 1/200 - 1/1000
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- Purified antibody in PBS with 0.05 % sodium azide.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
- Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
-
-
: "Cytokeratin 5 and estrogen receptor immunohistochemistry as a useful adjunct in identifying atypical papillary lesions on breast needle core biopsy." in: The American journal of surgical pathology, Vol. 33, Issue 11, pp. 1615-23, (2009) (PubMed).
: "Epidermolysis bullosa nevus arising in a patient with Dowling-Meara type epidermolysis bullosa simplex with a novel K5 mutation." in: The Journal of dermatology, Vol. 36, Issue 8, pp. 447-52, (2009) (PubMed).
-
: "Cytokeratin 5 and estrogen receptor immunohistochemistry as a useful adjunct in identifying atypical papillary lesions on breast needle core biopsy." in: The American journal of surgical pathology, Vol. 33, Issue 11, pp. 1615-23, (2009) (PubMed).
-
- Target
- Cytokeratin 5 (KRT5) (Keratin 5 (KRT5))
- Andere Bezeichnung
- CK5 (KRT5 Produkte)
- Hintergrund
-
Description: The protein encoded by this gene is a member of the keratin gene family. The type II cytokeratins consist of basic or neutral proteins which are arranged in pairs of heterotypic keratin chains coexpressed during differentiation of simple and stratified epithelial tissues. This type II cytokeratin is specifically expressed in the basal layer of the epidermis with family member KRT14. Mutations in these genes have been associated with a complex of diseases termed epidermolysis bullosa simplex. The type II cytokeratins are clustered in a region of chromosome 12q12-q13.
Aliases: KRT5, K5, DDD, EBS2, KRT5A
- Molekulargewicht
- 62.3kDa
- Gen-ID
- 3852
- HGNC
- 3852
- UniProt
- P13647
-
